Invasive pneumococcal disease surveillance, 1 January to 31 March 2016

Invasive pneumococcal disease surveillance, 1 January to 31 March 2016

Research output: Contribution to journal › Article › peer-review

Abstract

The number of notified cases of invasive pneumococcal disease (IPD) in the 1st quarter of 2016 was substantially fewer than the previous quarter and marginally less than the number of notified cases in the 1st quarter of 2015. Overall, the decline in disease due to the serotypes targeted by the 13-valent pneumococcal conjugate vaccine (13vPCV) has been maintained across all age groups since the 13vPCV replaced the 7-valent pneumococcal conjugate vaccine (7vPCV) in the childhood immunisation program from July 2011.

Original language	English
Pages (from-to)	E308-E312
Journal	Communicable Diseases Intelligence Quarterly Report
Volume	40
Issue number	2
Publication status	Published - 30 Jun 2016
Externally published	Yes

Cite this

@article{74d9929b96db4f359849f9bd06b6d37b,

title = "Invasive pneumococcal disease surveillance, 1 January to 31 March 2016",

abstract = "The number of notified cases of invasive pneumococcal disease (IPD) in the 1st quarter of 2016 was substantially fewer than the previous quarter and marginally less than the number of notified cases in the 1st quarter of 2015. Overall, the decline in disease due to the serotypes targeted by the 13-valent pneumococcal conjugate vaccine (13vPCV) has been maintained across all age groups since the 13vPCV replaced the 7-valent pneumococcal conjugate vaccine (7vPCV) in the childhood immunisation program from July 2011.",

author = "Kate Pennington and Anna Glynn-Robinson and Cindy Toms",

year = "2016",

month = jun,

day = "30",

language = "English",

volume = "40",

pages = "E308--E312",

journal = "Communicable Diseases Intelligence Quarterly Report",

issn = "1447-4514",

publisher = "Australian Government. Department of Health and Ageing. Office of Health Protection, Surveillance Branch",

number = "2",

}

TY - JOUR

T1 - Invasive pneumococcal disease surveillance, 1 January to 31 March 2016

AU - Pennington, Kate

AU - Glynn-Robinson, Anna

AU - Toms, Cindy

PY - 2016/6/30

Y1 - 2016/6/30

N2 - The number of notified cases of invasive pneumococcal disease (IPD) in the 1st quarter of 2016 was substantially fewer than the previous quarter and marginally less than the number of notified cases in the 1st quarter of 2015. Overall, the decline in disease due to the serotypes targeted by the 13-valent pneumococcal conjugate vaccine (13vPCV) has been maintained across all age groups since the 13vPCV replaced the 7-valent pneumococcal conjugate vaccine (7vPCV) in the childhood immunisation program from July 2011.

AB - The number of notified cases of invasive pneumococcal disease (IPD) in the 1st quarter of 2016 was substantially fewer than the previous quarter and marginally less than the number of notified cases in the 1st quarter of 2015. Overall, the decline in disease due to the serotypes targeted by the 13-valent pneumococcal conjugate vaccine (13vPCV) has been maintained across all age groups since the 13vPCV replaced the 7-valent pneumococcal conjugate vaccine (7vPCV) in the childhood immunisation program from July 2011.

UR - https://www.scopus.com/pages/publications/85011958936

M3 - Article

SN - 1447-4514

VL - 40

SP - E308-E312

JO - Communicable Diseases Intelligence Quarterly Report

JF - Communicable Diseases Intelligence Quarterly Report

IS - 2

ER -

Invasive pneumococcal disease surveillance, 1 January to 31 March 2016

Abstract

Other files and links

Fingerprint

Cite this